Comments

Spyre Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Spyre Therapeutics (SYRE) operate in?

Spyre Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

SYRENASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$17.71

-0.29-1.61%

At close: -

$17.71

0.000.00%

After Hours: 4:00 PM EDT

Spyre Therapeutics (SYRE) Forecast

News Earnings Spyre Therapeutics (SYRE) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Spyre Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:SYRE | Benzinga

Explore Spyre Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for SYRE.

Open	$17.67
Close	$17.71
Volume / Avg.	888.81K / 619.88K
Day Range	$17.22 - $18.03
52 Wk Range	10.91 - 40.26
Market Cap	$1.07B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	64
Short Interest	25.72%
Days to Cover	33.21

Recent News

This Weyerhaeuser Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Avi Kapoor

NIO Reports Upbeat Earnings, Joins Dave, V2X, Riskified And Other Big Stocks Moving Higher On Tuesday

U.S. stocks were lower, with the Dow Jones index falling more than 200 points on Tuesday.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$17.67
Close	$17.71
Volume / Avg.	888.81K / 619.88K
Day Range	$17.22 - $18.03
52 Wk Range	10.91 - 40.26
Market Cap	$1.07B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	64
Short Interest	25.72%
Days to Cover	33.21

About Spyre Therapeutics Inc.

Sector

Health Care

Industry

Biotechnology

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflamm...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Spyre Therapeutics (SYRE) stock?

You can purchase shares of Spyre Therapeutics (NASDAQ:SYRE) through any online brokerage.

View our list of the best stock brokerages

Who are Spyre Therapeutics (SYRE) competitors?

Other companies in Spyre Therapeutics’s space includes: Immunome (NASDAQ:IMNM), ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB), Cogent Biosciences (NASDAQ:COGT) and Syndax Pharmaceuticals (NASDAQ:SNDX).

What is the forecast, or price target, for Spyre Therapeutics (SYRE) stock?

Spyre Therapeutics has a consensus price target of $47.67.

What is the current price for Spyre Therapeutics (SYRE)?

The stock price for Spyre Therapeutics (NASDAQ: SYRE) is $17.71 last updated June 12, 2025 at 4:00 PM EDT.

Does Spyre Therapeutics (SYRE) pay a dividend?

There are no upcoming dividends for Spyre Therapeutics.

When is Spyre Therapeutics (NASDAQ:SYRE) reporting earnings?

Spyre Therapeutics’s Q2 earnings are confirmed for Wednesday, August 6, 2025.

Is Spyre Therapeutics (SYRE) going to split?

There is no upcoming split for Spyre Therapeutics.

What sector and industry does Spyre Therapeutics (SYRE) operate in?

Spyre Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.